Meenakshi Patel, MD
Geriatric Medicine · Centerville, OHNPI 1568458362
Payments from drug & device makers
Across 1,874 payments — averaging $2077.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2M
- GSK$503K
- Janssen Research & Development, LLC$342K
- Eisai Inc.$230K
- Lilly USA, LLC$165K
- Avanir Pharmaceuticals, Inc.$138K
- plus $555K from 53 others
Across 17 payments — averaging $5486.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$75K
- Genentech, Inc.$16K
- Acadia Pharmaceuticals Inc$2K
What the payments were for
- Consulting fees$95,37115%
- Speaking & faculty fees$462,32372%
- Travel & lodging$63,88510%
- Food & beverage$22,2623%
- Education$3420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRULICITY$147,737
- REXULTI$126,316
- GEMTESA$62,616
- XARELTO$43,613
- Yupelri$35,988
- LOKELMA$34,248
- Austedo XR$25,692
- AUSTEDO$23,214
- EZALLOR SPRINKLE$16,893
- APTIOM$16,125
- Kerendia$15,908
- KAPSPARGO$11,824
- ENTRESTO$11,697
- LONHALA MAGNAIR$10,966
- INGREZZA$5,546
- Wixela Inhub$5,127
- DRIZALMA SPRINKLE$5,122
- XIFAXAN$938
- NEXLIZET$125
- NEXLETOL$125
How this compares
$3,892,933 in reported general payments places this provider in the 95th percentile of 146 geriatric medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 650 | $209,706 |
| XareltoRivaroxaban | 454 | $156,444 |
| TrulicityDulaglutide | 136 | $145,765 |
| EliquisApixaban | 406 | $142,543 |
| EntrestoSacubitril/Valsartan | 248 | $105,507 |
| GemtesaVibegron | 283 | $88,319 |
| RebifInterferon Beta-1a/Albumin | 21 | $81,333 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 85 | $74,139 |
| ProliaDenosumab | 28 | $49,915 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 71 | $38,206 |
| NuedextaDextromethorphan Hbr/Quinidine | 49 | $37,934 |
| OzempicSemaglutide | 27 | $36,582 |
| YupelriRevefenacin | 20 | $28,251 |
| KerendiaFinerenone | 22 | $27,855 |
| FarxigaDapagliflozin Propanediol | 47 | $26,819 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $9,486 | $209,706650 claims |
| Johnson & JohnsonXarelto | $44,632 | $156,444454 claims |
| Lilly USA, LLCTrulicity | $165,368 | $145,765136 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Breo Ellipta | $502,675 | $144,422246 claims |
| PfizerEliquis | $37,003 | $142,543406 claims |
| NovartisEntresto | $12,216 | $105,507248 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $13,007 | $88,319283 claims |
| AmgenProlia, Epogen | $594 | $58,42752 claims |
| AstraZenecaFarxiga, Lokelma, Brilinta | $35,762 | $57,017113 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $137,795 | $37,93449 claims |
| Novo NordiskOzempic | $188 | $36,58227 claims |
| Mylan Specialty L.p.Yupelri | $24,975 | $28,25120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 146 geriatric medicine providers in Ohio.
Other geriatric medicine in Centerville
- Gurjeet KahlonCenterville$8K
- Babak TousiCleveland$8.6M
- Robert KeyesCincinnati$624K
- Daniel CannoneWadsworth$423K
- James FidelholtzCincinnati$392K
- Brinder VijWest Chester$92K
- Sean CannoneCopley$74K
- Andrew GrubbsCincinnati$52K
- Tai-Chi KwokWooster$26K
- Rodney IsonCanal Fulton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.